Axel Gaston Glasmacher
Vorsitzender bei 4D PHARMA PLC
Aktive Positionen von Axel Gaston Glasmacher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
4D PHARMA PLC | Independent Dir/Board Member | 08.01.2019 | - |
Vorsitzender | 17.04.2020 | - | |
Direktor/Vorstandsmitglied | 08.01.2019 | 17.04.2020 | |
RYVU THERAPEUTICS S.A. | Direktor/Vorstandsmitglied | 01.10.2019 | - |
ACTIVE BIOTECH AB | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Independent Dir/Board Member | 01.01.2020 | - | |
The Cancer Drug Development Forum | Direktor/Vorstandsmitglied | - | - |
Treasurer | - | - | |
AG Life Science Consulting Gmbh & Co. Kg | Vorstandsvorsitzender | - | - |
Direktor/Vorstandsmitglied | 01.03.2018 | - | |
Glasmacher Verwaltungs GmbH | Vorstandsvorsitzender | - | - |
Direktor/Vorstandsmitglied | - | - | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Direktor/Vorstandsmitglied | 01.07.2021 | - |
Karriereverlauf von Axel Gaston Glasmacher
Ehemalige bekannte Positionen von Axel Gaston Glasmacher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CELGENE | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2006 | 01.02.2018 |
Ausbildung von Axel Gaston Glasmacher
University of Bonn | Doctorate Degree |
Statistik
International
Deutschland | 4 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
4D PHARMA PLC | Health Technology |
RYVU THERAPEUTICS S.A. | Health Technology |
ACTIVE BIOTECH AB | Health Technology |
Private Unternehmen | 5 |
---|---|
The Cancer Drug Development Forum | |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
AG Life Science Consulting Gmbh & Co. Kg | |
Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
- Börse
- Insiders
- Axel Gaston Glasmacher
- Erfahrung